DrugPatentWatch Database Preview
MEPHYTON Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Mephyton, and when can generic versions of Mephyton launch?
The generic ingredient in MEPHYTON is phytonadione. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for MEPHYTON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 57 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,525 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MEPHYTON at DailyMed |
Pharmacology for MEPHYTON
| Ingredient-type | Vitamin K |
| Drug Class | Vitamin K Warfarin Reversal Agent |
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
Synonyms for MEPHYTON
| .alpha.-Phylloquinone |
| (R*,R*-(E))-(1)-2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone |
| [r-[r*,R*-(E)]]-2-Methyl-3-(3-7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione |
| [r-[r*,R*-(E)]]-2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-napthalenedione |
| 1, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- |
| 1, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, [R-[R*,R*-(E)]]- |
| 1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl)- |
| 1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)- |
| 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- |
| 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, (R-(R*,R*-(E)))- |
| 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, [R-[R*,R*-(E)]]- |
| 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, radical ion(1-), (R-(R*,R*-(E)))- |
| 1,4-Naphthalenedione,2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]- |
| 1,4-Naphthoquinone, 2-methyl-3-phytyl- |
| 10485-69-5 |
| 11104-38-4 |
| 12001-79-5 |
| 15973-57-6 |
| 2-(3,7,11,15-Tetramethyl-2-hexadecenyl)-3-methyl-1,4-naphthoquinone |
| 2-Methyl-3-(3,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione |
| 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione |
| 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione |
| 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1,4-dihydronaphthalene-1,4-dione |
| 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-dione |
| 2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone |
| 2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone # |
| 2-methyl-3-[(2E)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1,4-dihydronaphthalene-1,4-dione |
| 2-Methyl-3-[(2Z)-3,7,11,15-tetramethyl-2-hexadecenyl]-1,4-naphthoquinone |
| 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione |
| 2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione |
| 2-Methyl-3-phythyl-1,4-naphthochinon |
| 2-Methyl-3-phytyl-1,4-naphthochinon |
| 2-Methyl-3-phytyl-1,4-naphthochinon [German] |
| 2-Methyl-3-phytyl-1,4-naphthoquinone |
| 2-Methyl-3-phytyl-1,4-napthoquinone |
| 2', 3'-trans-Vitamin K1 |
| 2',3'-trans-Vitamin K1 |
| 214V063 |
| 27696-10-2 |
| 3-((2E)-3,7,11,15-tetramethylhexadec-2-enyl)-2-methylnaphthalene-1,4-dione |
| 3-Phytylmenadione |
| 50926-17-5 |
| 79083-00-4 |
| 81818-54-4 |
| 84-80-0 |
| 84C51B31-3CE2-476B-BE66-A84BDD46A513 |
| A-8090 |
| a-Phylloquinone |
| A840928 |
| AB00698065_04 |
| AC1NQX34 |
| AC1NR4R3 |
| AC1Q6B3J |
| AKOS015841892 |
| AKOS024284357 |
| alpha-Phylloquinone |
| Antihemorrhagic vitamin |
| Aqua mephyton |
| Aqua-Mephytin |
| Aquamephyton |
| AS-13734 |
| AT-6461 |
| BC206222 |
| BDBM24782 |
| BIDD:GT0793 |
| BT000807 |
| C02059 |
| C31H46O2 |
| CAS-84-80-0 |
| CCG-213568 |
| CHEBI:18067 |
| CHEBI:94399 |
| CHEMBL1550 |
| CHEMBL520156 |
| Combinal K1 |
| CPD000059144 |
| CPD001491672 |
| CS-6376 |
| D00148 |
| D07QPA |
| DB01022 |
| DR002790 |
| DSSTox_CID_3472 |
| DSSTox_GSID_23472 |
| DSSTox_RID_77041 |
| DTXSID8023472 |
| EBD2157931 |
| EINECS 201-564-2 |
| EINECS 234-330-3 |
| EINECS 234-408-7 |
| EINECS 279-052-3 |
| EINECS 279-833-9 |
| Fitomenadiona |
| Fitomenadiona [INN-Spanish] |
| Fitomenadione |
| Fitomenadione [DCIT] |
| HMS2094G09 |
| HMS2232C17 |
| HMS2270J10 |
| HSDB 3162 |
| HY-N0684 |
| J10207 |
| K-Ject |
| K516 |
| Kativ N |
| Kephton |
| Kinadion |
| Konakion |
| LMPR02030028 |
| LP083496 |
| LS-94617 |
| MBWXNTAXLNYFJB-LKUDQCMESA-N |
| MBWXNTAXLNYFJB-NKFFZRIASA-N |
| MFCD00214063 |
| MLS001074732 |
| MLS001332659 |
| MLS001332660 |
| MolPort-001-785-978 |
| MolPort-003-666-819 |
| MolPort-044-724-018 |
| Mono-Kay |
| Monodion |
| NCGC00159423-02 |
| NCGC00159423-03 |
| NCGC00186656-01 |
| NSC 270681 |
| NSC-270681 |
| NSC-760373 |
| NSC270681 |
| NSC760373 |
| P0642 |
| Pharmakon1600-01505485 |
| Phyllochinon |
| Phyllochinon [German] |
| Phyllochinonum |
| Phylloquinone |
| Phylloquinone (K1), analytical standard |
| phylloquinone;2-METHYL-3-PHYTYL-1,4-NAPHTHOQUINONE |
| Phythyl-menadion |
| Phythyl-menadion (GERMAN) |
| Phytomenadione |
| Phytomenadione, European Pharmacopoeia (EP) Reference Standard |
| Phytomenadionum |
| Phytomenadionum [INN-Latin] |
| phytonadione |
| Phytonadione (JP17/USP) |
| Phytonadione [USP:JAN] |
| Phytonadione, K1 |
| Phytonadione, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Phytonadione, United States Pharmacopeia (USP) Reference Standard |
| phytonadione|||trans-Phylloquinone |
| Phytonadionum |
| Phytylmenadione |
| phytylmenaquinone |
| PQN |
| Q-201934 |
| S5Z3U87QHF |
| SAM002564257 |
| SAM002643512 |
| SBI-0206926.P001 |
| SC-13299 |
| SCHEMBL351365 |
| SCHEMBL3882 |
| SMR000059144 |
| SMR000112043 |
| ST075162 |
| Synthex P |
| Tox21_111655 |
| Tox21_111655_1 |
| TR-026208 |
| trans-Phylloquinone |
| UNII-A034SE7857 component MBWXNTAXLNYFJB-NKFFZRIASA-N |
| UNII-S5Z3U87QHF |
| VITAMIN K |
| Vitamin K (generic) |
| Vitamin K 1 |
| vitamin K hydroquinone (phylloquinone) |
| Vitamin K semiquinone radical |
| VITAMIN K1 |
| Vitamin K1 1g |
| Vitamin K1 (Phylloquinone) |
| Vitamin K1 (Phytonadione) |
| Vitamin K1 (VAN) |
| Vitamin K1 solution, 10 mug/mL in ethanol, certified reference material |
| vitamin K1, 11 |
| Vitamin K1, BioXtra, >=99.0% (sum of isomers, HPLC), mixtur of isomers |
| Vitamin K1, viscous liquid |
| Vitamin K1(20) |
| VitaminK1 |
| W-108488 |
| ZINC3831332 |
US Patents and Regulatory Information for MEPHYTON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms | MEPHYTON | phytonadione | TABLET;ORAL | 010104-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
